The FDA had a busy June, clearing multiple solutions designed to treat patients with cardiovascular conditions. 

Detecting plaque erosion can offer an early warning sign of restricted blood flow to the heart, which can cause heart attacks. 

The new meta-analysis included data from nearly 10,000 patients. 

Continuous and high-adherent statin users had lower baseline arterial stiffness, which also grew more slowly over time. 

The test works by picking up on subtle blood flow changes that are often a precursor to major medical events.